Literature DB >> 33136753

Cross-Sectional and Longitudinal Performance of Creatinine- and Cystatin C-Based Estimating Equations Relative to Exogenously Measured Glomerular Filtration Rate in HIV-Positive and HIV-Negative Persons.

Gregory M Lucas1, Mohamed G Atta1, Katie Zook1, Dhananjay Vaidya1, Xueting Tao1, Paula Maier2, George J Schwartz2.   

Abstract

BACKGROUND: Reliable estimates of glomerular filtration rate (GFR) are important in the clinical management of HIV-positive patients. Data on the performance of widely used estimating equations (eGFR) relative to exogenously measured GFR are sparse in this population.
METHODS: We evaluated cross-sectional and longitudinal accuracy and bias of eGFR, based on creatinine and cystatin C, relative to disappearance of infused iohexol from plasma (iGFR) in a cohort of participants followed annually for up to 7 years.
RESULTS: A total of 222 HIV-positive and 139 HIV-negative participants contributed 1240 visits with valid iGFR and eGFR measures. Estimated GFR based on both creatinine and cystatin C performed the best. Estimated GFR based on creatinine alone overestimated iGFR by 9 mL·min·1.73 m on average and was significantly less accurate in HIV-positive than HIV-negative individuals. The performance of equations based on either creatinine alone or cystatin C alone were significantly affected by participant factors (eg, non-suppressed HIV RNA, nadir CD4 count, hepatitis C virus coinfection). The average iGFR slope was -4% per year in HIV-positive participants. In both HIV-positive and HIV-negative participants, eGFR slope measures were generally unbiased but inaccurate, with only 60%-74% of observations falling within ±5% points of iGFR slope.
CONCLUSIONS: Both creatinine and cystatin C have limitations as GFR indices in HIV-positive individuals. Estimated GFR based on both creatinine and cystatin C performed best in our study and may be preferred in HIV-positive persons with kidney disease or comorbidities that place them at high risk for kidney disease.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33136753      PMCID: PMC8301492          DOI: 10.1097/QAI.0000000000002471

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  24 in total

1.  Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations.

Authors:  Yuen-Ting Diana Kwong; Lesley A Stevens; Elizabeth Selvin; Yaping Lucy Zhang; Tom Greene; Frederick Van Lente; Andrew S Levey; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2010-07       Impact factor: 8.860

Review 2.  Assessment of Glomerular Filtration Rate in Health and Disease: A State of the Art Review.

Authors:  A S Levey; L A Inker
Journal:  Clin Pharmacol Ther       Date:  2017-06-05       Impact factor: 6.875

Review 3.  Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program.

Authors:  Gary L Myers; W Greg Miller; Josef Coresh; James Fleming; Neil Greenberg; Tom Greene; Thomas Hostetter; Andrew S Levey; Mauro Panteghini; Michael Welch; John H Eckfeldt
Journal:  Clin Chem       Date:  2005-12-06       Impact factor: 8.327

4.  Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.

Authors:  Gregory M Lucas; Michael J Ross; Peter G Stock; Michael G Shlipak; Christina M Wyatt; Samir K Gupta; Mohamed G Atta; Kara K Wools-Kaloustian; Paul A Pham; Leslie A Bruggeman; Jeffrey L Lennox; Patricio E Ray; Robert C Kalayjian
Journal:  Clin Infect Dis       Date:  2014-09-17       Impact factor: 9.079

5.  Glomerular filtration rate via plasma iohexol disappearance: pilot study for chronic kidney disease in children.

Authors:  G J Schwartz; S Furth; S R Cole; B Warady; A Muñoz
Journal:  Kidney Int       Date:  2006-06       Impact factor: 10.612

6.  Cystatin C- and creatinine-based equations in the assessment of renal function in HIV-positive patients prior to commencing Highly Active Antiretroviral Therapy.

Authors:  Tebogo Seape; Verena Gounden; Hendrick E van Deventer; Geoffrey P Candy; Jaya A George
Journal:  Ann Clin Biochem       Date:  2015-03-12       Impact factor: 2.057

7.  Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection.

Authors:  Sharon L Walmsley; Antonio Antela; Nathan Clumeck; Dan Duiculescu; Andrea Eberhard; Felix Gutiérrez; Laurent Hocqueloux; Franco Maggiolo; Uriel Sandkovsky; Catherine Granier; Keith Pappa; Brian Wynne; Sherene Min; Garrett Nichols
Journal:  N Engl J Med       Date:  2013-11-07       Impact factor: 91.245

8.  Factors other than glomerular filtration rate affect serum cystatin C levels.

Authors:  Lesley A Stevens; Christopher H Schmid; Tom Greene; Liang Li; Gerald J Beck; Marshall M Joffe; Marc Froissart; John W Kusek; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey
Journal:  Kidney Int       Date:  2008-12-31       Impact factor: 10.612

9.  Glomerular filtration rate estimated using creatinine, cystatin C or both markers and the risk of clinical events in HIV-infected individuals.

Authors:  G M Lucas; A Cozzi-Lepri; C M Wyatt; F A Post; A M Bormann; N F Crum-Cianflone; M J Ross
Journal:  HIV Med       Date:  2013-09-11       Impact factor: 3.180

10.  HIV viremia and T-cell activation differentially affect the performance of glomerular filtration rate equations based on creatinine and cystatin C.

Authors:  Bhavna Bhasin; Bryan Lau; Mohamed G Atta; Derek M Fine; Michelle M Estrella; George J Schwartz; Gregory M Lucas
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

View more
  1 in total

1.  Racial Adjustment Adversely Affects Glomerular Filtration Estimates in Black Americans Living with HIV.

Authors:  Mohamed G Atta; Katie Zook; Todd T Brown; Dhananjay Vaidya; Xueting Tao; Paula Maier; George J Schwartz; Gregory M Lucas
Journal:  J Am Soc Nephrol       Date:  2021-06-17       Impact factor: 14.978

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.